Furthermore, in multivariate Cox’s regression analyses, patients with a low CMG2 protein expression exhibited a significant 4.7-fold increased risk for tumor-related death (p = 0.047; see Figure 3d). The gene discussed is ANTXR2; the disease is neoplasm.